VITAF — Pharmaceutical Centre SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Pharmaceutical Centre SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.67 | 3.73 | 2.22 | 1.73 | 5.65 |
| Depreciation | |||||
| Non-Cash Items | 0.341 | 0.835 | 0.315 | 0.742 | -0.728 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.66 | -1.38 | -0.469 | 8.06 | -2.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.557 | 3.42 | 2.32 | 10.8 | 2.79 |
| Capital Expenditures | -0.374 | -2.1 | -0.802 | -0.14 | -0.161 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.001 | 1.43 | -1.41 | 1.69 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.374 | -2.1 | 0.63 | -1.55 | 1.53 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.05 | -3.99 | -2.86 | -5.64 | -5.92 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.23 | -2.66 | 0.089 | 3.65 | -1.6 |